AlphaYouMS
Insider selling
Michael Schmertzler sold $158K of Ptc Therapeutics, Inc. (PTCT) stock
Michael Schmertzler, Dir of Ptc Therapeutics, Inc. (PTCT), sold 2,500 shares of PTCT stock worth $158K, per an SEC Form 4 filed Oct 9, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 7, 2026, 2 days before it was made public.
PTCT has moved -1.1% since the trade date, from $63.23 to $62.56 (Oct 8, 2026 close).
- Traded
- Oct 7, 2026
- Disclosed
- Oct 9, 2026
- Filing delay
- 2 days
- Price since
- -1.1%
- Role
- Dir
- Source
- SEC Form 4
More PTCT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.